Skip to content
10-Q

Quarterly Report

FILANA THERAPEUTICS, INC. FLNA

0001437749-25-034427

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 48.31M sh
Shares Diluted Q3 2025 · Sep 30, 2025 48.31M sh
Shares Diluted Q3 2025 · Sep 30, 2025 48.29M sh
Shares Diluted Q3 2025 · Sep 30, 2024 47.98M sh
Shares Diluted Q3 2025 · Sep 30, 2024 46.1M sh
Capex Q3 2025 · Sep 30, 2025 $80K
Capex Q3 2025 · Sep 30, 2024 $46K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$22.5M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$55.66M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $106.08M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $128.57M
Stockholders Equity Q3 2025 · Sep 30, 2025 $81.57M
Stockholders Equity Q3 2025 · Jun 30, 2025 $87.97M
Stockholders Equity Q3 2025 · Mar 31, 2025 $127.62M
Stockholders Equity Q3 2025 · Dec 31, 2024 $145.7M
Stockholders Equity Q3 2025 · Sep 30, 2024 $166.64M
Stockholders Equity Q3 2025 · Jun 30, 2024 $188.97M
Stockholders Equity Q3 2025 · Mar 31, 2024 $78.6M
Stockholders Equity Q3 2025 · Dec 31, 2023 $137.47M
Current Liabilities Q3 2025 · Sep 30, 2025 $48.05M
Current Liabilities Q3 2025 · Dec 31, 2024 $11.75M
Total Liabilities Q3 2025 · Sep 30, 2025 $48.17M
Total Liabilities Q3 2025 · Dec 31, 2024 $11.83M
Current Assets Q3 2025 · Sep 30, 2025 $108.91M
Current Assets Q3 2025 · Dec 31, 2024 $136.53M
Total Assets Q3 2025 · Sep 30, 2025 $129.73M
Total Assets Q3 2025 · Dec 31, 2024 $157.53M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.22
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.62
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.58
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.88
Eps Basic Q3 2025 · Sep 30, 2025 −$0.22
Eps Basic Q3 2025 · Sep 30, 2025 −$1.62
Eps Basic Q3 2025 · Sep 30, 2024 −$0.58
Eps Basic Q3 2025 · Sep 30, 2024 $0.07
Sga Expense Q3 2025 · Sep 30, 2025 $7.91M
Sga Expense Q3 2025 · Sep 30, 2025 $59.1M
Sga Expense Q3 2025 · Sep 30, 2024 $12.95M
Sga Expense Q3 2025 · Sep 30, 2024 $62.85M
Rd Expense Q3 2025 · Sep 30, 2025 $3.96M
Rd Expense Q3 2025 · Sep 30, 2025 $22.74M
Rd Expense Q3 2025 · Sep 30, 2024 $17.68M
Rd Expense Q3 2025 · Sep 30, 2024 $49.11M
Net Income Q3 2025 · Sep 30, 2025 −$10.81M
Net Income Q3 2025 · Sep 30, 2025 −$78.43M
Net Income Q3 2025 · Jun 30, 2025 −$44.22M
Net Income Q3 2025 · Mar 31, 2025 −$23.4M
Net Income Q3 2025 · Sep 30, 2024 −$27.94M
Net Income Q3 2025 · Sep 30, 2024 $3.26M
Net Income Q3 2025 · Jun 30, 2024 $6.16M
Net Income Q3 2025 · Mar 31, 2024 $25.04M
Operating Income Q3 2025 · Sep 30, 2025 −$11.86M
Operating Income Q3 2025 · Sep 30, 2025 −$81.84M
Operating Income Q3 2025 · Sep 30, 2024 −$30.62M
Operating Income Q3 2025 · Sep 30, 2024 −$111.96M